Generation and characterization of novel monoclonal antibodies to the Ret receptor tyrosine kinase.

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Biochemical and Biophysical Research Communications - BBRC

• Publication date

  2002-06-21

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/S0006-291X(02)00560-0PMID 12061779
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Immunotoxins for targeted cancer therapy

  2006cited by this paper
• Improved cytotoxic activity toward cell lines and fresh leukemia cells of a mutant anti-CD22 immunotoxin obtained by antibody phage display.

  2002cited by this paper
• New cytotoxic agents and schedules for advanced breast cancer.

  2001cited by this paper
• Expression and alternative splicing of c-ret RNA in papillary thyroid carcinomas

  2001cited by this paper
• Efficacy of the anti-CD22 recombinant immunotoxin BL22 in chemotherapy-resistant hairy-cell leukemia.

  2001cited by this paper
• Monoclonal antibodies.

  2000cited by this paper
• Regulation of cell fate decision of undifferentiated spermatogonia by GDNF.

  2000cited by this paper
• RET receptor expression in thyroid follicular epithelial cell-derived tumors.

  2000cited by this paper
• The RET proto-oncogene in human cancers

  2000influential reference
• Improved Gene Transfer to Neuroblastoma Cells by a Monoclonal Antibody Targeting RET, a Receptor Tyrosine Kinase

  2000cited by this paper
• Glial cell line-derived neutrotrophic factor and neurturin can act as paracrine growth factors stimulating DNA synthesis of Ret-expressing spermatogonia.

  2000cited by this paper
• Therapeutic monoclonal antibodies.

  2000cited by this paper
• Of mice and men: hybridoma and recombinant antibodies.

  2000cited by this paper
• Implication of expression of GDNF/Ret signalling components in differentiation of bone marrow haemopoietic cells

  1999cited by this paper
• The RET receptor tyrosine kinase, but not its specific ligand, GDNF, is preferentially expressed by acute leukaemias of monocytic phenotype and is up‐regulated upon differentiation

  1999cited by this paper
• Activation of RET as a dominant transforming gene by germline mutations of MEN2A and MEN2B

  1995cited by this paper
• trk and ret proto‐oncogene expression in human neuroblastoma specimens: High frequency of trk expression in non‐advanced stages

  1993cited by this paper
• Identification of the ret proto-oncogene products in neuroblastoma and leukemia cells.

  1991cited by this paper
• Expression of the ret proto-oncogene in human neuroblastoma cell lines and its increase during neuronal differentiation induced by retinoic acid.

  1991cited by this paper
• The ret proto-oncogene is consistently expressed in human pheochromocytomas and thyroid medullary carcinomas.

  1990cited by this paper
• Specific expression of the ret proto-oncogene in human neuroblastoma cell lines.

  1990cited by this paper

• Exploiting RET isoforms in managing medullary and papillary thyroid cancer

  2018cites this paper
• Essential role for Bim in mediating the apoptotic and antitumor activities of immunotoxins

  2017cites this paper
• Modeling human MLL-AF9 translocated acute myeloid leukemia from single donors reveals RET as a potential therapeutic target

  2017cites this paper
• RET and Thyroid Carcinomas

  2015cites this paper
• New approaches for breast cancer: should Ret kinase be considered as a novel therapeutic target?

  2014cites this paper
• RET recognition of GDNF-GFRα1 ligand by a composite binding site promotes membrane-proximal self-association.

  2014cites this paper
• RET Recognition of GDNF-G FR a 1 Ligand by a Composite Binding Site Promotes Membrane-Proximal Self-Association Graphical

  2014cites this paper
• Mammal-restricted elements predispose human RET to folding impairment by HSCR mutations

  2010cites this paper
• Medullary Thyroid Cancer: Molecular Biology and Novel Molecular Therapies

  2009cites this paper
• RET oncogene in MEN2, MEN2B, MTC and other forms of thyroid cancer

  2008cites this paper
• Doctorate Program in Molecular Oncology and Endocrinology

  2006cites this paper
• Characterization of the B Cell Epitopes Associated with a Truncated Form of Pseudomonas Exotoxin (PE38) Used to Make Immunotoxins for the Treatment of Cancer Patients1

  2006cites this paper
• PatientsImmunotoxins for the Treatment of Cancer Exotoxin (PE38) Used to Make Pseudomonas Associated with a Truncated Form of Characterization of the B Cell Epitopes

  2006cites this paper
• Minireview: RET: normal and abnormal functions.

  2004cites this paper
• DNA immunization followed by a single boost with cells: a protein-free immunization protocol for production of monoclonal antibodies against the native form of membrane proteins.

  2003cites this paper